Evolent Health Inc
NYSE:EVH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Evolent Health Inc
Net Income
Evolent Health Inc
Net Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Evolent Health Inc
NYSE:EVH
|
Net Income
-$534.5m
|
CAGR 3-Years
-203%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Net Income
$908.9m
|
CAGR 3-Years
23%
|
CAGR 5-Years
19%
|
CAGR 10-Years
32%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Net Income
$145.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Net Income
$223.2m
|
CAGR 3-Years
13%
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
|
|
Omnicell Inc
NASDAQ:OMCL
|
Net Income
$2.1m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
-24%
|
|
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
Net Income
$112.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Evolent Health Inc
Glance View
Evolent Health Inc. emerged in 2011 from a collaboration between The Advisory Board Company and the University of Pittsburgh Medical Center, with a mission to reshape healthcare delivery in the United States. As the healthcare landscape shifted towards value-based care models, where providers are compensated for keeping patients healthy rather than on the volume of services delivered, Evolent positioned itself as a pivotal partner for healthcare systems aiming to transition smoothly into this new paradigm. The company's core offerings revolve around its technology-driven platform, which integrates data analytics, care management, and clinical expertise to enable healthcare providers and payers to deliver more efficient and patient-centric care. By providing these services, Evolent helps its clients reduce costs and improve patient outcomes, thus thriving in a rapidly evolving industry. From a business perspective, Evolent Health generates revenue primarily through two streams: provider services and performance-based contracts. For its provider services, Evolent signs agreements with healthcare providers, offering them proprietary technology and consulting services, all designed to enhance their operational efficiency and clinical capabilities. The performance-based contracts, which are fundamental in a value-based care environment, allow Evolent to share in the financial benefits realized by its clients from improved patient care and cost savings. This model not only aligns Evolent's success with that of its clients but also positions the company at the heart of the healthcare value chain, asserting its influence through partnerships that are financially symbiotic.
See Also
What is Evolent Health Inc's Net Income?
Net Income
-534.5m
USD
Based on the financial report for Dec 31, 2025, Evolent Health Inc's Net Income amounts to -534.5m USD.
What is Evolent Health Inc's Net Income growth rate?
Net Income CAGR 5Y
-10%
Over the last year, the Net Income growth was -767%. The average annual Net Income growth rates for Evolent Health Inc have been -203% over the past three years , -10% over the past five years .